Our providers review your history, current health status, and weight management goals, walk through your options, and determine whether a tirzepatide based treatment is clinically appropriate for you
51.4% of Patients Would Consider Using GLP-1 Drugs Again 51.4% of participants said they would use GLP-1s again
Have something small now, even just broth
General Introduction The liver is a major target organ in safety assessment of preclinical toxicity and oncogenicity studies with rodents
Patients and providers alike have noticed that while these two medications share a common mechanism, their approval indications, dosing protocols, and efficacy rates hint at significant differences
What Is Not Normal During Treatment Serious reactions during an IV session are rare, but recognizing them early is what separates a minor scare from a real problem